ADA Scientific Sessions 2026 Abstract
Efficacy and Hypoglycemia Outcomes with Once-Weekly IcoSema vs. Comparators in T2D by Baseline BMI: COMBINE 1–3
Trial in peopleInterventions
Papers by Raluca Maltesen
4 results
- ADA Scientific Sessions 2026 Abstract
CGM-Based Metrics in Insulin-Naive Adults with T2D Receiving IcoSema vs. Glargine U100: Post Hoc Analysis of COMBINE 4.
Trial in peopleInterventions - ADA Scientific Sessions 2026 Abstract
Efficacy and Hypoglycemia Outcomes with Once-Weekly IcoSema vs. Comparators in T2D by Baseline A1C: COMBINE 1–3
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
CGM-Derived Model-Based Postprandial Glucose with IcoSema vs. Other Insulin Regimens—A Post Hoc Analysis of COMBINE 1 and 3
Trial in peopleInterventions